Screener
Arcus Biosciences RCUS Accrued research and development
Accrued research and development at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept rcus:AccruedResearchAndDevelopmentExpensesCurrent.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's accrued research and development?
- Arcus Biosciences (RCUS) reported accrued research and development of $98M in Q2 2026.
- How has Arcus Biosciences's accrued research and development changed year-over-year?
- Arcus Biosciences's accrued research and development increased by 60.7% year-over-year, from $61M to $98M.
- What is the long-term trend for Arcus Biosciences's accrued research and development?
- Over 5 years (2020 to 2025), Arcus Biosciences's accrued research and development has grown at a 37.2% compound annual growth rate (CAGR), from $18.31M to $89M.
- What does accrued research and development mean?
- Accrued research and development as reported by Arcus Biosciences, Inc..
Ask your AI about Arcus Biosciences's accrued research and development.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude